NEWS
News Articles
Missing our great physicist Sérgio Mascarenhas, defender of science
The passing of the scientist, physicist and chemist was mourned by all those who believe in scientific development, democratization of education and science as a way to build a fairer society in Brazil, with more health and access to all. Professor at the Institute of Physics of São Carlos, University of São Paulo, and honorary…
Read MoreBioMarin Pharmaceutical commemorates 5 years of helping children with fatal rare disease
CLN2 Batten disease is a rare, inherited, fatal disorder that primarily affects the nervous system as a result of a failure to produce enough of the enzyme TPP1. The signs and symptoms of this condition typically start between the ages of 2 and 4, featuring recurrent seizures and coordination difficulty. BioMarin Pharmaceutical in San Rafael…
Read MoreSaol Therapeutics and InformedDNA Partner to Offer Genetic Counseling to Patients with Rare Mitochondrial Disease
Program Discusses Access to a Pivotal Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency (DCA/PDCD trial; NCT02616484) Saol Therapeutics, a company researching new treatments for rare diseases, is pleased to announce a partnership with InformedDNA®, the nation’s leading applied genomics solutions company, to offer genetic counseling for the families of individuals with a…
Read MoreGeorgia Bio Names South Forsyth High School Junior as 2022 Georgia BioGENEius Winner
Mokshith Mannuru Advances to International Competition Against Top Students Georgia Bio and the BioEd Institute named Mokshith Mannuru, a junior at South Forsyth High School in Cumming, GA, as the winner of the 2022 Georgia BioGENEius Challenge. The BioGENEius Challenge is the premier competition for high school students that recognizes outstanding research and innovation in the…
Read MoreGeorgia Bio Names 2022 Golden Helix Award Winners
Clearside Biomedical’s Rafael Andino and The Georgia Institute of Technology’s Krishnendu Roy to be Honored with Top Award ATLANTA, GA (April 11, 2022) – Georgia Bio, the state’s life science trade association, will celebrate its annual Golden Helix Awards on Thursday, May 5th. Georgia Bio is pleased to announce the winners of the 2022 Golden…
Read MorePfizer to Acquire ReViral for Up to $525M, Expanding RSV Pipeline
Pfizer has agreed to acquire ReViral, a developer of antiviral therapeutics targeting respiratory syncytial virus (RSV), for up to $525 million, the companies said today, in a deal designed to meet the unmet need for RSV treatments by adding ReViral’s infectious disease pipeline and R&D capabilities to those of the buyer. Read full article here
Read More